These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36066183)

  • 1. No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in Milan.
    Masetti C; Colapietro F; Voza A; Aghemo A
    Liver Int; 2022 Nov; 42(11):2581-2582. PubMed ID: 36066183
    [No Abstract]   [Full Text] [Related]  

  • 2. No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan.
    Masetti C; Colapietro F; Voza A; Aghemo A
    Liver Int; 2022 Dec; 42(12):2921-2922. PubMed ID: 36004560
    [No Abstract]   [Full Text] [Related]  

  • 3. [The incidence of alcoholic liver disease in Japan (1976-1985)].
    Takeuchi J; Okudaira M; Takada A; Ohta Y; Tsujii T; Itoh S; Fujisawa K; Tanikawa K; Hasumura Y
    Nihon Shokakibyo Gakkai Zasshi; 1987 Aug; 84(8):1623-30. PubMed ID: 2826850
    [No Abstract]   [Full Text] [Related]  

  • 4. Alcoholic liver disease--epidemiology and risk factors.
    Cojocariu CE; Trifan AV; Gîrleanu I; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):910-7. PubMed ID: 25581947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current status of acute-on-chronic liver failure in patients with alcoholic liver cirrhosis in Japan].
    Nakayama N
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(1):30-38. PubMed ID: 35022368
    [No Abstract]   [Full Text] [Related]  

  • 6. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
    Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to: 'No impact of Covid-19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan'.
    Gonzalez HC; Rupp LB; Trudeau S; Gordon SC
    Liver Int; 2022 Aug; 42(8):1910-1911. PubMed ID: 35670429
    [No Abstract]   [Full Text] [Related]  

  • 8. The Changing Global Epidemiology of Hepatocellular Carcinoma.
    Caines A; Selim R; Salgia R
    Clin Liver Dis; 2020 Nov; 24(4):535-547. PubMed ID: 33012444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden: a population-based study.
    Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
    Scand J Gastroenterol; 2019 Aug; 54(8):1027-1032. PubMed ID: 31389730
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013.
    Sahlman P; Nissinen M; Pukkala E; Färkkilä M
    Int J Cancer; 2016 Jun; 138(11):2616-21. PubMed ID: 26756434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of alcoholic liver disease and hepatitis C.
    Marsano LS; Peña LR
    Hepatogastroenterology; 1998; 45(20):331-9. PubMed ID: 9638402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of alcoholic liver diseases in Japan].
    Horie Y; Ebinuma H; Kanai T
    Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1630-40. PubMed ID: 26346353
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic liver disease in Japan.
    Ohnishi K; Okuda K
    J Clin Gastroenterol; 1986 Oct; 8(5):503-8. PubMed ID: 3023474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Alcohol-Associated Liver Disease.
    Han S; Yang Z; Zhang T; Ma J; Chandler K; Liangpunsakul S
    Clin Liver Dis; 2021 Aug; 25(3):483-492. PubMed ID: 34229835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
    Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
    Aniemeka C; Pillai AA
    Dig Dis Sci; 2022 Aug; 67(8):3483-3484. PubMed ID: 35288830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.